GridAI Technologies (GRDX) Share-based Compensation Growth (3y) (2019 - 2025)
GridAI Technologies (GRDX) Share-based Compensation Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.91% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 17.49% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.95% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.55% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 7.39% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 30.98% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.12% |
| Dec 31, 2024 | -26.00% |
| Sep 30, 2024 | -44.94% |
| Jun 30, 2024 | -51.38% |
| Mar 31, 2024 | -43.44% |
| Dec 31, 2023 | -8.92% |
| Sep 30, 2023 | -50.72% |
| Jun 30, 2023 | 18.33% |
| Mar 31, 2023 | 132.87% |
| Dec 31, 2022 | 114.51% |
| Sep 30, 2022 | 209.39% |
| Jun 30, 2022 | 43.81% |
| Mar 31, 2022 | -38.49% |
| Dec 31, 2021 | -54.03% |
| Sep 30, 2021 | 235.92% |
| Jun 30, 2021 | 64.10% |
| Mar 31, 2021 | 272.51% |
| Dec 31, 2020 | 54.04% |
| Sep 30, 2020 | 290.95% |
| Jun 30, 2020 | 5.84% |